The Latest in Hematology News

These adverse events linked to improved cancer prognosis

September 28, 2023

Mixed Topics

FDA approves bosutinib for children with CML

September 28, 2023

Dispelling clinicians’ misconceptions about sickle cell disease

September 28, 2023

Pediatrician with SCD gives her young patients hope

September 27, 2023

How targeted drugs can vanquish a virulent leukemia

September 25, 2023

AML

Nationwide hematologists shortage: What’s being done?

September 20, 2023

FDA approves JAK inhibitor momelotinib for myelofibrosis with anemia

September 18, 2023

Artificial intelligence in your office

September 15, 2023

Business of Medicine

Debate: Should smoldering myeloma be treated?

September 14, 2023

Multiple Myeloma

Safely skip PET2 after brentuximab in Hodgkin lymphoma?

September 13, 2023

High rate of subsequent cancers in MCC

September 13, 2023

Non-Hodgkin Lymphoma

FDA approves motixafortide for stem cell mobilization in myeloma

September 11, 2023

Is additional treatment needed, pretransplant, for r/r AML?

September 11, 2023

Seeking help for burnout may be a gamble for doctors

September 11, 2023

Business of Medicine

Using JAK inhibitors for myelofibrosis

September 11, 2023